Vestor Capital’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41K Sell
580
-2,165
-79% -$171K ﹤0.01% 275
2025
Q4
$48K Buy
2,745
+1,887
+220% +$147K ﹤0.01% 245
2025
Q3
$64K Sell
858
-901
-51% -$67.2K ﹤0.01% 239
2025
Q2
$628K Buy
1,759
+901
+105% +$62.7K 0.05% 98
2025
Q1
$69K Sell
858
-7
-0.8% -$602 0.01% 210
2024
Q4
$68K Buy
865
+7
+0.8% +$595 0.01% 225
2024
Q3
$81K Hold
858
0.01% 192
2024
Q2
$67K Hold
858
0.01% 204
2024
Q1
$78K Buy
858
+200
+30% +$16.6K 0.01% 198
2023
Q4
$51K Hold
658
﹤0.01% 219
2023
Q3
$45K Hold
658
﹤0.01% 232
2023
Q2
$53K Hold
658
0.01% 237
2023
Q1
$54K Buy
+658
New +$47K 0.01% 218

Other funds holding GEHC

Vestor Capital's GEHC Position: Q1 2026 in Review

Vestor Capital reduced its GE HealthCare (GEHC) stake by 79% in Q1 2026, selling an estimated $171K and leaving 580 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #275.

Vestor Capital first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $628K in Q2 2025. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Vestor Capital held 580 shares of GE HealthCare worth $41K as of Q1 2026.
  • Vestor Capital sold 2,165 GE HealthCare shares in Q1 2026, an estimated $171K.
  • GE HealthCare made up ﹤0.01% of Vestor Capital's portfolio in Q1 2026, its #275 holding.
  • Vestor Capital first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Vestor Capital's GE HealthCare position peaked at $628K in Q2 2025.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Vestor Capital's 13F filing for Q1 2026, filed 21 May 2026.